In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form
Evgeniy A Gorbunov, Irina A Ertuzun, Evgeniya V Kachaeva, Sergey A Tarasov, Oleg I EpsteinOOO “NPF “MATERIA MEDICA HOLDING”, Moscow, Russian FederationAbstract: Experimentally and clinically, it was shown that released-active form of antibodies to S100 protein (RAF of A...
Guardado en:
Autores principales: | Gorbunov EA, Ertuzun IA, Kachaeva EV, Tarasov SA, Epstein OI |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6471bba13d9341a68856c071ab3664de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Level of neurotransmitters in neuroamine-containing lung structures in different forms of tuberculosis
por: N. Gimaldinova, et al.
Publicado: (2019) -
Therapeutic value of the metabolomic active neurotransmitter isorhynchophylline in the treatment of spontaneously hypertensive rats by regulating neurotransmitters
por: Alharbi Homood, et al.
Publicado: (2021) -
Inhibition of Calpains Protects Mn-Induced Neurotransmitter release disorders in Synaptosomes from Mice: Involvement of SNARE Complex and Synaptic Vesicle Fusion
por: Can Wang, et al.
Publicado: (2017) -
AIP limits neurotransmitter release by inhibiting calcium bursts from the ryanodine receptor
por: Bojun Chen, et al.
Publicado: (2017) -
Loss of Ahi1 impairs neurotransmitter release and causes depressive behaviors in mice.
por: Liyan Ren, et al.
Publicado: (2014)